Addition of GPI-0100 did not significantly increase the E7-specific CD8+ T cell response detected in peripheral blood, suggesting that the cisplatin treatment primed or served as an adjuvant to TA-CIN vaccination in the tumor bearing mice. Here, CD8A is linked to neoplasm.